跳至主要内容
临床试验/DRKS00010413
DRKS00010413已完成未知

Comparison of the therapeutic benefit to combination therapy of botulinum neurotoxin and cast as well as single dose of botulinum neurotoxin on the wrist spasticity in different time intervals

eurologisches Rehabilitationszentrum Leipzig0 个研究点目标入组 60 人开始时间: 2016年6月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Aged 18 years - stoke with spasticity of the upper limb -MAS 2 - 3 - noticeable catch (according to Tardieu Scale) -pROM wrist affected: = 0 ° in extension

排除标准

  • - Age <18 years - MAS = 1+ or> 3 - wrist is not up to the 0 position (PROM) mobilized - no meaningful catch (Tardieu Scale) - fixed contracture of the fingers and / or wrist - Serious additional diseases - severe communication disorder - myasthenia gravis, Lambert-Eaton syndrome, ALS or other serious neuromuscular diseases - severe dysphagia - current administration of aminoglycosides - proven hypersensitivity to Clostridium botulinum toxin A or any of the excipients of the preparation Dysport® - Planned operations within the next 12 weeks ago - pregnancy, lactation period - anticoagulant therapy (Warfarin, Falithrom) - infections in the injection area and skin damage in the area of ??castings - Significant edematous swelling of the arm and hand - Peri-articular heterotrophic ossification in the investigation area - Unstable fractures in the study area - gout and diseases of rheumatic at the involved joints (upper limb)

研究者

发起方
eurologisches Rehabilitationszentrum Leipzig

相似试验